Preparing Heart & Mind™: A Patient Engagement Pathway for Parents & Their

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of this study is to test and evaluate the Preparing Heart and Mind™ (PHM™) patient engagement pathway as a nurse-guided intervention to lower psychological distress and enhance caregiving competencies among mothers/birthing persons and their caregiving partners after a major fetal anomaly diagnosis.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT06046989` - Building Emotional Awareness and Mental Health in Parenting (BEAM)	N/A
	Terminated	`NCT01777724` - Evaluation of a Parenting and Stress Management Programmme	N/A

NCT number	NCT05282368
Study type	Interventional
Source	University of Minnesota
Contact
Status	Completed
Phase	N/A
Start date	November 1, 2020
Completion date	March 1, 2023

Preparing Heart and Mind™: A Patient Engagement Pathway for Parents and Their Caregiving Partners After a Major Fetal Anomaly Diagnosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms